Xunyao Biotechnology

About:

Xunyao Biotech is a cutting-edge medication development company focused on coagulation and fibrosis.

Top Investors: Shanghai Biomedical Industrial Equity Investment Fund, Longpan Investment

Description:

Xunyao Biotech is a cutting-edge medication development company focused on coagulation and fibrosis. Xunyao Biotech specializes on the research and development of novel pharmaceuticals in the disciplines of coagulation and fibrosis.

Total Funding Amount:

200M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2021-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-01-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai